MARKET

RVPH

RVPH

Reviva Pharmaceutcls Hldgs Inc
OTCMQB
0.465
-0.005
-1.06%
Opening 14:09 08/14 EDT
OPEN
0.465
PREV CLOSE
0.470
HIGH
0.520
LOW
0.465
VOLUME
4.65K
TURNOVER
2.30K
52 WEEK HIGH
23.20
52 WEEK LOW
0.262
MARKET CAP
6.10M
P/E (TTM)
-0.1021
1D
5D
1M
3M
1Y
5Y
1D
OTC Market Listing Exposes Reviva Pharmaceuticals to Volatility, Illiquidity and Pricing Risks
TipRanks · 12h ago
Reviva Pharmaceuticals Q2 EPS $(0.19) Beats $(0.39) Estimate
Benzinga · 1d ago
Reviva Pharmaceuticals GAAP EPS of -$0.19 beats by $0.17
Seeking Alpha · 1d ago
*Reviva Pharm Holdings 2Q Loss/Shr 19c >RVPH
Dow Jones · 1d ago
Weekly Report: what happened at RVPH last week (0803-0807)?
Weekly Report · 4d ago
Weekly Report: what happened at RVPH last week (0727-0731)?
Weekly Report · 08/03 10:01
Weekly Report: what happened at RVPH last week (0720-0724)?
Weekly Report · 07/27 10:04
Weekly Report: what happened at RVPH last week (0713-0717)?
Weekly Report · 07/20 10:01
More
About RVPH
Reviva Pharmaceuticals Holdings, Inc. is a late-stage pharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates, brilaroxazine (RP5063) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).

Webull offers Reviva Pharmaceuticals Holdings Inc stock information, including OTCMQB: RVPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPH stock methods without spending real money on the virtual paper trading platform.